CervoMed Inc. Increase (Decrease) in Employee Related Liabilities
CervoMed Inc. (CRVO) reported Increase (Decrease) in Employee Related Liabilities of $267.15 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2014-05-20
- CervoMed Inc. increase (decrease) in employee related liabilities for the quarter ending 2014-03-31 was $267.15K, a 47.14% increase year-over-year.
- CervoMed Inc. increase (decrease) in employee related liabilities for the quarter ending 2013-12-31 was -$854.04K.
- CervoMed Inc. increase (decrease) in employee related liabilities for the quarter ending 2013-09-30 was $29.89K, a 92.75% decline year-over-year.
- CervoMed Inc. increase (decrease) in employee related liabilities for the quarter ending 2013-06-30 was $60.99K, a 90.23% decline year-over-year.
- CervoMed Inc. increase (decrease) in employee related liabilities for fiscal 2013 was -$581.61K, a 150.45% decline from fiscal 2012.
- CervoMed Inc. increase (decrease) in employee related liabilities for fiscal 2012 was $1.15M, a 1591.39% increase from fiscal 2011.
- CervoMed Inc. increase (decrease) in employee related liabilities for fiscal 2011 was $68.17K, a 76.75% decline from fiscal 2010.
- CervoMed Inc. increase (decrease) in employee related liabilities for fiscal 2010 was $293.13K.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2014-03-31 | $267.15K 10-Q · filed 2014-05-20 | -$586.89K derived: sum of 2 quarters · filed 2014-05-20 | -$557.00K derived: sum of 3 quarters · filed 2014-05-20 | -$496.01K derived: sum of 4 quarters · filed 2014-05-20 |
| 2013-12-31 | -$854.04K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | -$824.15K derived: sum of 2 quarters · filed 2014-04-23 | -$763.16K derived: sum of 3 quarters · filed 2014-04-23 | -$581.61K 10-K/A · filed 2014-04-23 |
| 2013-09-30 | $29.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $90.88K derived: sum of 2 quarters · filed 2013-11-19 | $272.43K 10-Q · filed 2013-11-19 | $199.92K derived: sum of 4 quarters · filed 2014-05-20 |
| 2013-06-30 | $60.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $242.55K 10-Q · filed 2013-08-14 | $170.04K derived: sum of 3 quarters · filed 2014-05-20 | $582.44K derived: sum of 4 quarters · filed 2014-05-20 |
| 2013-03-31 | $181.56K 10-Q · filed 2014-05-20 | $109.05K derived: sum of 2 quarters · filed 2014-05-20 | $521.45K derived: sum of 3 quarters · filed 2014-05-20 | $1.15M derived: sum of 4 quarters · filed 2014-05-20 |
| 2012-12-31 | -$72.51K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $339.89K derived: sum of 2 quarters · filed 2014-04-23 | $963.97K derived: sum of 3 quarters · filed 2014-04-23 | $1.15M 10-K/A · filed 2014-04-23 |
| 2012-09-30 | $412.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $1.04M derived: sum of 2 quarters · filed 2013-11-19 | $1.23M 10-Q · filed 2013-11-19 | $1.28M derived: sum of 4 quarters · filed 2013-11-19 |
| 2012-06-30 | $624.08K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-14 | $813.04K 10-Q · filed 2013-08-14 | $866.30K derived: sum of 3 quarters · filed 2013-08-14 | $934.60K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $188.96K 10-Q/A · filed 2013-05-20 | $242.22K derived: sum of 2 quarters · filed 2013-05-20 | $310.53K derived: sum of 3 quarters · filed 2013-05-20 | |
| 2011-12-31 | $53.26K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | $121.56K derived: sum of 2 quarters · filed 2013-04-24 | $68.17K 10-K/A · filed 2013-04-24 | |
| 2011-09-30 | $68.30K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $14.90K 10-Q · filed 2012-11-19 | ||
| 2011-06-30 | -$53.40K 10-Q/A · filed 2012-09-07 | |||
| 2010-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-21 | $138.75K derived: sum of 2 quarters · filed 2012-05-21 | $293.13K 10-K · filed 2012-05-21 | |
| 2010-09-30 | $78.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | $233.13K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $154.38K 10-Q · filed 2011-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |